Skip to main content
Daniel Javitt, MD, Psychiatry, New York, NY

Daniel C. Javitt MD PhD

Psychopharmacology


Director, Division of Experimental Therapeutics Director, Columbia Conte Center for Schizophrenia Research Professor of Psychiatry and Neuroscience Columbia University College of Physicians and Surgeons New York, NY Director, Division of Schizophrenia Research Nathan Kline Institute for Psychiatric Research Orangeburg, NY

Join to view full profile
  • 1051 Riverside DrUnit 21New York, NY 10032

  • Phone+1 212-543-5475

  • Fax+1 212-543-5668

Dr. Javitt is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Psychiatry, 1986 - 1987
  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Psychiatry, 1984 - 1986
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1983

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1984 - 2027
  • MD State Medical License
    MD State Medical License 2009 - 2010
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Multicenter Study of Ketamine Effects on Functional Connectivity: Large Scale Network Relationships, Hubs and Symptom Mechanisms  
    Ragy R Girgis, Richard J Maddock, John D Ragland, Daniel C Javitt, Cameron S Carter, Joshua T Kantrowitz, Jeffrey Lieberman, John H Krystal, Lawrence S Kegeles, Willia..., ScienceDirect
  • American Psychiatric Association Publishing  
    Cheryl M Corcoran, Daniel C Javitt, National Institutes of Health
  • Sensory and Cross-Network Contributions to Response Inhibition in Patients with Schizophrenia  
    Daniel C Javitt, Matthew J Hoptman, ScienceDirect

Press Mentions

  • Pharma Consortium Publishes Results of Large EEG/ERP Biomarker Study in Subjects with Schizophrenia and Healthy Volunteers
    Pharma Consortium Publishes Results of Large EEG/ERP Biomarker Study in Subjects with Schizophrenia and Healthy VolunteersMarch 16th, 2023
  • CUIMC Update - Sept. 13, 2021
    CUIMC Update - Sept. 13, 2021September 13th, 2021
  • NRx Pharmaceuticals, Inc. Commences Trading on Nasdaq as NRXP, Following Merger Between NeuroRx, Inc. And Big Rock Partners Acquisition Corp (Nasdaq:BRPA)
    NRx Pharmaceuticals, Inc. Commences Trading on Nasdaq as NRXP, Following Merger Between NeuroRx, Inc. And Big Rock Partners Acquisition Corp (Nasdaq:BRPA)May 25th, 2021

Grant Support

  • Sensory contributions to third visual pathway dysfunction in schizophrenia: correlation and causationNATHAN S. KLINE INSTITUTE FOR PSYCH RES2025–2030
  • A Schizophrenia Extension Study for the NKI Rockland Sample II project: An Open Resource of Multimodal Brain, Physiology & Behavior from a Community Lifespan SampleNATHAN S. KLINE INSTITUTE FOR PSYCH RES2024–2029
  • Use of alpha-frequency deep transcranial interference stimulation (tIS) to understand and modify temporal dynamics of face emotion recognition and social/affective function.COLUMBIA UNIVERSITY HEALTH SCIENCES2024–2028
  • Auditory event-related potentials as in vivo preclinical assays of circuit engagement for E/I-based therapeutic developmentNATHAN S. KLINE INSTITUTE FOR PSYCH RES2023–2028
  • Auditory event-related potentials as in vivo preclinical assays of circuit engagement for E/I-based therapeutic developmentNATHAN S. KLINE INSTITUTE FOR PSYCH RES2023–2028

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: